Beginning of the end of hepatitis B in Australia?

November 14, 2012
Beginning of the end of hepatitis B in Australia?
Hepatitis B virus in between human cells.

(Medical Xpress)—A newborn vaccination program first introduced for Aboriginal babies in the Northern Territory has made significant inroads, significantly helping in the push to eradicate chronic hepatitis B infection in Australia.

Researchers from UNSW's Kirby Institute and the Northern Territory's Department of Health have published a study in the international journal Vaccine that shows rates of infection are 80 per cent lower in young Aboriginal women born since the program began in 1988, compared to those born before the program began.

In Aboriginal women from remote communities, the decrease has seen rates fall from five per cent to one per cent, the study, conducted by UNSW's Kirby Institute in collaboration with the Northern Territory Department of Health, shows.

Researchers say it may be expected that a similar decline will be seen in other Australian states and territories once children vaccinated from 2000 onwards become old enough to be included in hepatitis B testing programs.

Hepatitis B is a potentially life-threatening infection that causes liver cirrhosis, and .

The study findings highlight the importance of immunisation programs in preventing chronic diseases such as hepatitis B, the researchers say.

Explore further: Follow-up lacking for babies after hepatitis B vaccination: CDC

Related Stories

Follow-up lacking for babies after hepatitis B vaccination: CDC

September 27, 2012
(HealthDay)—Many U.S. babies born to mothers infected with hepatitis B do not receive recommended follow-up testing after vaccination, a new study finds.

Hepatitis C kills more Americans than HIV: study

February 23, 2012
More Americans died in 2007 of hepatitis C infection, which causes incurable liver disease, than from the virus that causes AIDS, US health authorities said this week.

Antiviral therapy may halve risk of liver cancer after chronic hepatitis C infection

October 22, 2012
Treating chronic hepatitis C infection with antiviral drugs could halve the risk of developing the most common form of liver cancer, in some cases, indicates an analysis of the published research in one of the new BMJ Open ...

Analysis finds mortality from all causes higher among hepatitis C-infected

June 10, 2011
Although liver-related mortality among those infected with hepatitis C is well-documented, little is known about deaths in these patients that are not related to liver problems. A new study published in Clinical Infectious ...

Hepatitis B and liver cancer among Asian Americans

June 21, 2012
(Medical Xpress) -- Liver cancer is expected to become more common in the United States in coming years.  “It’s deadly and it’s preventable,” says UCSF physician and researcher Tung Nguyen, MD.

The economic cost of advanced liver disease

November 7, 2011
Health care costs for hepatitis C patients with end-stage liver disease are nearly 2.5 times higher than those in the early stages, according to a Henry Ford Hospital study.

Recommended for you

Zika virus stifles pregnant women's weakened immune system to harm baby, study finds

August 21, 2017
The Zika virus, linked to congenital birth defects and miscarriages, suppresses a pregnant woman's immune system, enabling the virus to spread and increasing the chances an unborn baby will be harmed, a Keck School of Medicine ...

Novel approach to track HIV infection

August 18, 2017
Northwestern Medicine scientists have developed a novel method of tracking HIV infection, allowing the behavior of individual virions—infectious particles—to be connected to infectivity.

Faulty gene linked to obesity in adults

August 18, 2017
Groundbreaking new research linking obesity and metabolic dysfunction to a problem in the energy generators in cells has been published by researchers from the Harry Perkins Institute of Medical Research and The University ...

Two lung diseases killed 3.6 million in 2015: study

August 17, 2017
The two most common chronic lung diseases claimed 3.6 million lives worldwide in 2015, according to a tally published Thursday in The Lancet Respiratory Medicine.

New test differentiates between Lyme disease, similar illness

August 16, 2017
Lyme disease is the most commonly reported vector-borne illness in the United States. But it can be confused with similar conditions, including Southern Tick-Associated Rash Illness. A team of researchers led by Colorado ...

Addressing superbug resistance with phage therapy

August 16, 2017
International research involving a Monash biologist shows that bacteriophage therapy – a process whereby bacterial viruses attack and destroy specific strains of bacteria - can be used successfully to treat systemic, multidrug ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.